Kaposi Sarcoma and KSHV Transmission in MSM and Other High Risk Groups

Sheena M. Knights, MD
Assistant Professor, Division of Infectious Diseases and Geographic Medicine
Department of Internal Medicine
University of Texas Southwestern Medical Center, Dallas, TX



CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Sheena M. Knights, MD is an Assistant Professor in the Department of Internal Medicine at the University of Texas Southwestern (UTSW) Medical Center and a member of the Division of Infectious Diseases and Geographic Medicine. She is the Associate Program Director of the HIV Fellowship program. Dr. Knights holds a bachelor's degree in chemistry from Princeton University. She earned her medical degree and completed internal medicine residency training at Baylor College of Medicine in Houston, Texas. She then completed an infectious diseases fellowship at the University of Texas Southwestern Medical Center prior to joining UTSW as faculty in 2019. Dr. Knights’s clinical interest includes a focus on HIV care. Her research interests include HIV-associated Kaposi’s sarcoma, epidemiology of KSHV, and healthcare disparities.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Know the 3 most common conditions caused by KSHV in patients with HIV.
2. Understand which patients are at highest risk for KSHV-related disease by reviewing KSHV epidemiology and transmission mechanisms.
3. Recognize risk factors for mortality in HIV-associated Kaposi's sarcoma.

CME Information:Top of page


This CME activity has approved for AMA PRA Category 1 Credit™ for July 12th, 2023 as a live activity.  This activity will also be available as an enduring activity from July 19th, 2023, through July 11th, 2026.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) had no relevant financial relationships to disclose.
- Dr. Ofole Mgbako (Moderator) had no relevant financial relationships to disclose.
- Dr. Sheena M. Knights (Presenter) had no relevant financial relationships to disclose. Dr. Knights submitted her slides in advance for adequate peer review and supported her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register